Title:
ORAL SUSTAINED RELEASE FORMULATION OF TEDISAMIL WITH GASTRIC RETENTION PROPERTIES
Document Type and Number:
WIPO Patent Application WO2006000583
Kind Code:
A3
Abstract:
The present invention relates to a novel sustained release formulation with gastric retention properties comprising tedisamil or a pharmaceutically acceptable salt thereof and the use of this formulation in the prevention and treatment of atrial fibrillation, atrial flutter and cardiac ischemia.
Inventors:
BAKKER JOHAN A (NL)
DE WINTER MARIUS L (NL)
FABIANO SANTA (NL)
DE WINTER MARIUS L (NL)
FABIANO SANTA (NL)
Application Number:
PCT/EP2005/052984
Publication Date:
October 12, 2006
Filing Date:
June 27, 2005
Export Citation:
Assignee:
SOLVAY PHARM BV (NL)
BAKKER JOHAN A (NL)
DE WINTER MARIUS L (NL)
FABIANO SANTA (NL)
BAKKER JOHAN A (NL)
DE WINTER MARIUS L (NL)
FABIANO SANTA (NL)
International Classes:
A61P9/06; A61K9/20
Domestic Patent References:
| WO2002026214A1 | 2002-04-04 |
Other References:
See also references of EP 1763338A2
Download PDF:
Previous Patent: CONTROL PANEL FOR AN ELECTRICAL DOMESTIC APPLIANCE
Next Patent: SECURITY MODULE AND METHOD OF CUSTOMISING ONE SUCH MODULE
Next Patent: SECURITY MODULE AND METHOD OF CUSTOMISING ONE SUCH MODULE